Colorectal cancer is often found in members of a same family, suggesting a strong hereditary component.
This is the reason why Nicole Beauchemin and her team are looking for a genetic signature of the disease. This very promising research will help identify individuals presenting genetic predispositions to the disease before It develops and keep them one step ahead of cancer.
“My first grant as a researcher was from the cancer research society back in 1989. It’s been vivital I have a very particular position as researcher. I developed and was treated for breast cancer. What this has given me is to understand from a close-up perspective what a patient goes though in terms of treatment.
It has been rather incredible because we are finding signatures that will now identify patients who eventually could develop colorectal cancer, which means they will be able to be followed clinically and avoid that they develop it.”
The Cancer Research Society funds highly promising research projects undertaken by Canada’s best scientists. Following a rigorous peer review selection process, about 150 researchers are thus able to advance scientific knowledge to improve cancer prevention, detection and treatments, through various funding programs. These programs are based on scientific excellence, support to new generations of scientists, support to promising underfunded research avenues and partnerships with great impact potential. Since its inception, the Cancer Research Society has thus contributed to major advances in oncology, helping position Canada at the forefront of cancer research in the world.